MALDI-MS derived prognostic protein markers for resected non-small cell lung cancer.

MLA

Xu, Baogang J., et al. “MALDI-MS Derived Prognostic Protein Markers for Resected Non-Small Cell Lung Cancer.” Proteomics - Clinical Applications, vol. 2, no. 10/11, Oct. 2008, pp. 1508–17. EBSCOhost, https://doi.org/10.1002/prca.200800094.

APA

Xu, B. J., Gonzalez, A. L., Kikuchi, T., Yanagisawa, K., Massion, P. P., Wu, H., Mason, S. E., Olson, S. J., Shyr, Y., Carbone, D. P., & Caprioli, R. M. (2008). MALDI-MS derived prognostic protein markers for resected non-small cell lung cancer. Proteomics - Clinical Applications, 2(10/11), 1508–1517. https://doi.org/10.1002/prca.200800094

Chicago

Xu, Baogang J., Adriana L. Gonzalez, Takefumi Kikuchi, Kiyoshi Yanagisawa, Pierre P. Massion, Huiyun Wu, Stephen E. Mason, et al. 2008. “MALDI-MS Derived Prognostic Protein Markers for Resected Non-Small Cell Lung Cancer.” Proteomics - Clinical Applications 2 (10/11): 1508–17. doi:10.1002/prca.200800094.